| 07/08/09 | Alnylam Joins GSK in Donating Intellectual Property to Patent Pool for Neglected Tropical Diseases |
| | RNAi technology could lead to new targets and treatments |
| 07/07/09 | Airgas Awarded NIST Contract for Standard Reference Materials (SRMs) |
| | Airgas-supplied and NIST-Certified SRM gas mixtures serve as the basis for production of EPA protocol gases used for calibrating emissions monitoring equipment
|
| 06/01/09 | Boston-Power Announces Plans to Build One of the World’s Most Advanced Lithium-ion Battery Manufacturing Plants in Massachusetts |
| | Governor Patrick, Congressman McGovern and Other Top Officials Pledge Support for Plan to Fuel Creation of 600 New Green Jobs
|
| 05/20/09 | New Energy Researchers to Coat Glass Windows with World’s Tiniest Working Solar Cells which Generate Electricity |
| | Tinted see-thru coating for generating electricity on glass windows makes use of ultra-small solar cells -- shown to produce electricity in recently published peer-reviewed study and able to generate electricity from natural and artificial light.
|
| 05/19/09 | LS9 and Procter & Gamble Launch Sustainable Chemicals Partnership |
| | Confirms P&G’s Commitment to Sustainable Innovation
|
| 04/17/09 | Newest Texas Wind Farm Cause for Community Celebration, Brings Energy Industry Leaders to Kenedy County on the Gulf Coast |
| | Texas leads the nation in producing the most renewable wind power, and the region’s newest wind farm was cause for community-wide celebration in Kenedy County along the Gulf Coast today. |
| 04/17/09 | Glycos Biotechnologies, Inc. Closes Series A Round of $5 Million |
| | Company to Use Funds for Commercialization of Innovative and Cost-Effective Bio-Processing Technologies
to Produce Chemicals from Low-Cost, Low-Value Carbon Sources |
| 04/08/09 | Silicon Valley Venture Capitalists’ Confidence Springs Back |
| | USF Report Reveals Insights from VC Community
|
| 04/07/09 | University City Science Center Launches Proof-of-Concept Funding Program |
| | The University City Science Center, in collaboration with key academic research partners, has launched a program to bridge the funding gap between research grants and private seed investment. |
| 04/01/09 | Altea Therapeutics Announces Development and Commercialization Agreement with Amylin and Lilly for an Investigational Transdermal Exenatide |
| | Altea Therapeutics to Receive Upfront License Payment, R&D Funding, and Equity Investment, Eligible for Future Milestones and for Royalties
|
| [ <- 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 -> ] |
RSS feed of TechConnect Wire™
